Division of Critical Care Medicine, College of Medicine, University of Cincinnati , Cincinnati, Ohio.
Cardiovascular Imaging Core of the Heart Institute Cincinnati Children's Hospital Medical Center, College of Medicine, University of Cincinnati , Cincinnati, Ohio.
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H826-H837. doi: 10.1152/ajpheart.00052.2018. Epub 2018 Jul 6.
Age represents a major risk factor for multiple organ failure, including cardiac dysfunction, in patients with sepsis. AMP-activated protein kinase (AMPK) is a crucial regulator of energy homeostasis that controls mitochondrial biogenesis by activation of peroxisome proliferator-activated receptor-γ coactivator-1α and disposal of defective organelles by autophagy. We investigated whether AMPK dysregulation contributes to age-dependent cardiac injury in young (2-3 mo) and mature adult (11-13 mo) male mice subjected to sepsis by cecal ligation and puncture and whether AMPK activation by 5-amino-4-imidazole carboxamide riboside affords cardioprotective effects. Plasma proinflammatory cytokines and myokine follistatin were similarly elevated in vehicle-treated young and mature adult mice at 18 h after sepsis. However, despite equivalent troponin I and T levels compared with similarly treated young mice, vehicle-treated mature adult mice exhibited more severe cardiac damage by light and electron microscopy analyses with more marked intercellular edema, inflammatory cell infiltration, and mitochondrial derangement. Echocardiography revealed that vehicle-treated young mice exhibited left ventricular dysfunction after sepsis, whereas mature adult mice exhibited a reduction in stroke volume without apparent changes in load-dependent indexes of cardiac function. At molecular analysis, phosphorylation of the catalytic subunits AMPK-α/α was associated with nuclear translocation of peroxisome proliferator-activated receptor-γ coactivator-1α in vehicle-treated young but not mature adult mice. Treatment with 5-amino-4-imidazole carboxamide riboside ameliorated cardiac architecture derangement in mice of both ages. These cardioprotective effects were associated with attenuation of the systemic inflammatory response and amelioration of cardiac dysfunction in young mice only, not in mature adult animals. NEW & NOTEWORTHY Our data suggest that sepsis-induced cardiac dysfunction manifests with age-dependent characteristics, which are associated with a distinct regulation of AMP-activated protein kinase-dependent metabolic pathways. Consistent with this age-related deterioration, pharmacological activation of AMP-activated protein kinase may afford cardioprotective effects allowing a partial recovery of cardiac function in young but not mature age.
年龄是导致脓毒症患者多器官衰竭(包括心功能障碍)的主要危险因素。 AMP 激活的蛋白激酶(AMPK)是能量代谢平衡的关键调节剂,通过激活过氧化物酶体增殖物激活受体-γ 共激活因子-1α 来控制线粒体生物发生,并通过自噬处理有缺陷的细胞器。我们研究了 AMPK 失调是否导致年轻(2-3 个月)和成熟成年(11-13 个月)雄性小鼠在盲肠结扎和穿刺诱导脓毒症后出现年龄依赖性心脏损伤,以及 AMPK 通过 5-氨基-4-咪唑甲酰胺核苷激活是否具有心脏保护作用。在脓毒症后 18 小时,用载体处理的年轻和成熟成年小鼠的血浆前炎性细胞因子和肌因子 follistatin 水平同样升高。然而,尽管与同样处理的年轻小鼠相比,troponin I 和 T 水平相当,但用载体处理的成熟成年小鼠的心脏损伤通过光镜和电镜分析更为严重,表现为更明显的细胞间水肿、炎症细胞浸润和线粒体紊乱。超声心动图显示,用载体处理的年轻小鼠在脓毒症后出现左心室功能障碍,而成熟成年小鼠在不明显改变心脏功能负荷依赖性指标的情况下,表现为每搏量减少。在分子分析中,在载体处理的年轻小鼠中,AMPK-α/α 的催化亚基的磷酸化与过氧化物酶体增殖物激活受体-γ 共激活因子-1α 的核转位相关,但在成熟成年小鼠中则不相关。5-氨基-4-咪唑甲酰胺核苷治疗改善了两个年龄段小鼠的心脏结构紊乱。这些心脏保护作用与全身炎症反应的减弱以及年轻小鼠而非成熟成年动物的心脏功能障碍的改善有关。新的和值得注意的是,我们的数据表明,脓毒症诱导的心脏功能障碍表现出与年龄相关的特征,这些特征与 AMP 激活的蛋白激酶依赖性代谢途径的不同调节有关。与这种与年龄相关的恶化一致,AMP 激活的蛋白激酶的药理学激活可能提供心脏保护作用,使年轻但不是成熟年龄的心脏功能部分恢复。